Whole-Body Electromyostimulation and Knee Osteoarthritis
EMSOAT
Whole-body Electromyostimulation for the Treatment of Knee Osteoarthritis (EMSOAT) in Overweight People - a Randomized Controlled Trial
1 other identifier
interventional
72
1 country
1
Brief Summary
The aim of the present study is to evaluate the effects of WB-EMS application in overweight women and men with knee osteoarthritis, with special consideration of sustainability. In this randomised controlled trial 72 overweight patients with knee osteoarthritis aged 40-70 years will be included and randomly assigned to two groups (WB-EMS vs. control group (CG)). The intervention group will perform six WB-EMS sessions/month of 20 min for 6 months. An intermittent low frequency WB-EMS-protocol with an impulse phase of 6s, followed by an impulse break of 4s will be applied. The control group will undergo a tailored physiotherapy program of 6 sessions defined as usual care. In addition, both groups will complete a self-management training programme for osteoarthritis of 6 sessions over 12 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 2, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedMay 8, 2024
December 1, 2022
1.4 years
January 2, 2023
May 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Knee pain
Changes in pain of the knee joint as determined by the Knee Injury and Osteoarthritis Outcome Score (KOOS) in the WB-EMS- compared to changes in the control group.KOOS score for "knee pain" vary from 1 (never/no pain) to 5 (always/very severe pain)
baseline to 6 month follow up
Secondary Outcomes (18)
Self rated symptoms
baseline to 6-month follow-up
Knee stiffness
baseline to 6-month follow-up
Function in daily living
baseline to 6-month follow-up
Function in sports and recreational activities
baseline to 6-month follow-up
Quality of Life
baseline to 6-month follow-up
- +13 more secondary outcomes
Other Outcomes (2)
Drop-out rate
baseline to 6-month follow-up
Attendance rate
baseline to 6-month follow-up
Study Arms (2)
WB-EMS group
EXPERIMENTALWB-EMS application
Control
ACTIVE COMPARATORStandardised physiotherapy (six sessions)
Interventions
Consistently supervised, video-guided WB-EMS application 1.5 times per week for 28 weeks. Bipolar electric current with a frequency of 85Hz, an impulse-width of 350 µs will be used in an interval approach with 6 sec of EMS stimulation with a direct impulse boost and 4 sec of rest. Low intensity movements or exercises in a standing position were performed during the 6 s stimulation period.
Eligibility Criteria
You may qualify if:
- overweight (BMI\>25 kg/m2)
- radiographically confirmed early to moderate femorotibial osteoarthritis (Kellgren- Lawrence grades 2 and 3)
- osteoarthritic knee pain for at least 3 months
- average pain intensity \> 2.5 (NRS 0-10)
You may not qualify if:
- WB-EMS in the last year or resistance exercise \>1 session/week in the last year
- present glucocorticoid or opioid medication
- trauma of the knee joint within the last 3 months
- intra-articular injections in the knee joint within the last 3 months
- malignant diseases
- serious cardiovascular diseases
- conditions or diseases that are contraindications for WB-EMS
- absence ≥3 weeks during the intervention period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Medical Physics University of Erlangen-Nurnberg
Erlangen, 91052, Germany
Related Publications (3)
Kemmler W, Kleinoder H, Frohlich M. Editorial: Whole-body electromyostimulation: A training technology to improve health and performance in humans? volume II. Front Physiol. 2022 Aug 5;13:972011. doi: 10.3389/fphys.2022.972011. eCollection 2022. No abstract available.
PMID: 36111142RESULTBloeckl J, Raps S, Weineck M, Kob R, Bertsch T, Kemmler W, Schoene D. Feasibility and Safety of Whole-Body Electromyostimulation in Frail Older People-A Pilot Trial. Front Physiol. 2022 Jun 24;13:856681. doi: 10.3389/fphys.2022.856681. eCollection 2022.
PMID: 35812334RESULTKemmler W, Shojaa M, Steele J, Berger J, Frohlich M, Schoene D, von Stengel S, Kleinoder H, Kohl M. Efficacy of Whole-Body Electromyostimulation (WB-EMS) on Body Composition and Muscle Strength in Non-athletic Adults. A Systematic Review and Meta-Analysis. Front Physiol. 2021 Feb 26;12:640657. doi: 10.3389/fphys.2021.640657. eCollection 2021.
PMID: 33716787RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie Kast, MSc
Institute of Radiology, University Hospital-Nürnberg
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2023
First Posted
January 5, 2023
Study Start
June 1, 2022
Primary Completion
October 31, 2023
Study Completion
April 1, 2024
Last Updated
May 8, 2024
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share